Clinical Research Directory
Browse clinical research sites, groups, and studies.
Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination
Sponsor: Center for Health Sciences, Serbia
Summary
This randomized, double-blind, placebo-controlled trial will evaluate whether 12 weeks of supplementation with the probiotic Lactobacillus rhamnosus GG combined with colon-delivered riboflavin will improve cognitive performance and brain physiology in older adults with memory complaints. The study will assess changes in cognitive outcomes together with neurophysiological markers to explore potential gut-brain axis mechanisms. Through its rigorous design, the trial will aim to determine whether targeted modulation of the intestinal environment can support brain function and cognitive health in aging.
Official title: Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination (MENTOR)
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2026-04-15
Completion Date
2027-08-15
Last Updated
2026-02-13
Healthy Volunteers
Yes
Conditions
Interventions
Experimental 1
Probiotic and riboflabin
Experimental 2
Microcrystaline cellulose